Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Combination of somatostatin-analogs with 11beta-hydroxylase inhibitors

US Patent 9333234 · Granted May 10, 2016

Estimated economic value: $17,190,000

Assignee

Inventors

View full patent text on Google Patents →